title: Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia.
abstract: We previously observed that Gadd45/MyD118, a member of the Gadd45 family of inducible factors, showed the strongest immediate-early induction common to two distinctive proliferation responses of the liver: (1) regeneration induced by surgical partial hepatectomy and (2) hyperplasia induced by the primary mitogen TCPOBOP, a ligand of the constitutive androstane receptor (CAR). Gadd45 is known to be stimulated by nuclear factor (NF) B, which is activated by tumor necrosis factor alpha (TNF) in the early response to partial hepatectomy. We therefore investigated whether TNF and NFB also stimulated Gadd45 as part of the response to CAR ligands, or whether activation occurred by an alternative pathway. TCPOBOP effects were characterized in three mouse genotypes: wild-type, TNFR1-/-, and TNFR1-/-TNFR2-/-. The results showed that TCPOBOP did not activate NFB in any of the mice, but a strong induction of Gadd45 messenger RNA was observed in all three genotypes, where TCPOBOP also induced CyP2b10, a classical target gene of activated CAR, and cyclin D1, a proliferation linked gene. Thus, the absence of TNFR signaling and induction of NFB did not impair CAR-mediated gene induction. Moreover, hepatocyte proliferation was strongly induced, and at significantly higher levels than wild type, in both TNFR1-/- and TNFR1-/-TNFR2-/- mice. Further studies evaluated TCPOBOP-induced gene expression in CAR-/- mice, by microarray expression profiling and Northern blot. The induced changes in gene expression, including the stimulation of Gadd45, were almost completely abolished--hence all were mediated via CAR activation. In conclusion, in the liver, Gadd45 can be induced by a distinctive pathway that requires CAR and is independent of TNF-NFB. The greater induction of proliferation in TNFR-null mice suggests negative cross-talk between the CAR and TNF-NFB controls that regulate proliferation.
authors.affiliation: Department of Toxicology, Oncology and Molecular Pathology Unit, University of Cagliari, Italy. columbano@unica.it
authors.forename: Amedeo
authors.initials: A
authors.lastname: Columbano
authors.forename: Giovanna M
authors.initials: GM
authors.lastname: Ledda-Columbano
authors.forename: Monica
authors.initials: M
authors.lastname: Pibiri
authors.forename: Costanza
authors.initials: C
authors.lastname: Cossu
authors.forename: Marta
authors.initials: M
authors.lastname: Menegazzi
authors.forename: David D
authors.initials: DD
authors.lastname: Moore
authors.forename: Wendong
authors.initials: W
authors.lastname: Huang
authors.forename: Jianmin
authors.initials: J
authors.lastname: Tian
authors.forename: Joseph
authors.initials: J
authors.lastname: Locker
mesh_terms: D000818:Animals; D000943:Antigens, Differentiation / Q000096:biosynthesis*; D049109:Cell Proliferation / Q000187:drug effects; D000090702:Constitutive Androstane Receptor; D005260:Female; D006965:Hyperplasia; D008099:Liver / Q000378:metabolism* / Q000473:pathology*; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D016328:NF-kappa B / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology; D018160:Receptors, Cytoplasmic and Nuclear / Q000172:deficiency / Q000378:metabolism*; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000172:deficiency; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000172:deficiency; D014157:Transcription Factors / Q000172:deficiency / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D000097642:GADD45 Proteins
chemical_list: D000943:Antigens, Differentiation; D000090702:Constitutive Androstane Receptor; D016328:NF-kappa B; D011725:Pyridines; D018160:Receptors, Cytoplasmic and Nuclear; D047888:Receptors, Tumor Necrosis Factor, Type I; D047889:Receptors, Tumor Necrosis Factor, Type II; D014157:Transcription Factors; D014409:Tumor Necrosis Factor-alpha; C490125:Gadd45b protein, mouse; D000097642:GADD45 Proteins; C028474:1,4-bis(2-(3,5-dichloropyridyloxy))benzene